Preparing for holiday travel and gatherings can help support both immune and emotional health. MinuteClinic® offers convenient in-person and virtual care, from preventive care and vaccinations to ...

CVS Health announced the CVS Health Community Equity Alliance is being established to expand the community health worker workforce, enhance connections between health care institutions and communities ...

At its 2023 Investor Day, CVS Health® shares how its strategy and combination of assets drives reliable, diversified, and accelerating earnings growth, while also delivering superior care and value to ...

CVS Health Appoints David Joyner President and Chief Executive OfficerRoger Farah Named Executive Chairman of the Board Company provides preliminary guidance for third quarter 2024 GAAP diluted ...

On May 29, 2025, CVS Health® filed a lawsuit to block Arkansas Act 624, a harmful law that will shut down 23 CVS Pharmacy® locations, eliminate hundreds of jobs and drive-up costs for Arkansans.

New business will bring high quality biosimilar products to market with goal of reducing drug spend and ensuring access to affordable medications Cordavis to launch biosimilar Hyrimoz® with Sandoz ...

Backed by the strength of CVS Health WOONSOCKET, R.I., Oct. 1, 2024 — Aetna®, a CVS Health® company (NYSE: CVS ), today announced our 2025 Medicare products bring together what matters most to our ...

Acquisition further advances CVS Health’s care delivery strategy for consumers WOONSOCKET, R.I., CHICAGO, Feb. 8, 2023 — CVS Health® (NYSE: CVS ) and Oak Street Health (NYSE: OSH ) have entered into a ...

CVS Health® announced Brian Newman has been named executive vice president and chief financial officer designate. Amy Compton-Phillips, MD, is the company’s new executive vice president and chief ...

CVS Health Board of Directors appoints four new members: Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman Appointments follow productive engagement with Glenview Capital Management ...

Updated COVID-19 vaccine now available at CVS Pharmacy® ...

Fourth quarter GAAP diluted EPS of $1.30 decreased from $1.58 in the prior year and Adjusted EPS of $1.19 decreased from $2.12 in the prior year, primarily due to a decline in the Health Care Benefits ...